16 January 2018
News and Views
Links and Services
November's publication of Alimentary Pharmacology & Therapeutics investigates maternal and fetal adverse events with tumor necrosis factor-alpha inhibitors in inflammatory bowel disease.
Transplacental transfer of tumour necrosis factor-alpha (TNF-α) inhibitors has been shown in
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors